European Respiratory Journal

The ERJ publishes clinical and experimental work relating to all aspects of adult and paediatric respiratory medicine, including cell biology, epidemiology, immunology, oncology, pathophysiology, imaging, occupational medicine, intensive care, sleep medicine and thoracic surgery. In addition to original research material, the ERJ also publishes editorial commentaries, reviews, short research letters and correspondence to the editor. Articles are published continuously and collected into 12 monthly issues in two volumes per year.

July

ERJ Podcast Eur Respir J 2015; 46: E55
The respiratory health benefits of quitting cannabis use Tashkin Donald P. Eur Respir J 2015; 46: 1-4
Animal fur and asthma: an indoor farmyard phenomenon? Crane Julian Eur Respir J 2015; 46: 5-7
Defining airflow limitation and chronic obstructive pulmonary disease: the role of outcome studies Culver Bruce Eur Respir J 2015; 46: 8-10
Cystic fibrosis in Europe: patients live longer but are we ready? Schwarz Carsten, Hartl Dominik Eur Respir J 2015; 46: 11-12
Never too old: beneficial neurobehavioural effects of continuous positive airway pressure in the elderly Bliwise Donald L. Eur Respir J 2015; 46: 13-15
Insights into idiopathic pulmonary fibrosis in the real world Cottin Vincent, Wuyts Wim Eur Respir J 2015; 46: 16-18
Targeted therapies: detrimental treatment for nonsmall cell lung cancer without driver mutations Berghmans Thierry, Meert Anne-Pascale, Quoix Elisabeth Eur Respir J 2015; 46: 19-21
The Transatlantic Trade and Investment Partnership: Trojan horse or positive force for health? Faure Marine, Ward Brian Eur Respir J 2015; 46: 22-25
ESR/ERS white paper on lung cancer screening Kauczor Hans-Ulrich, Bonomo Lorenzo, Gaga Mina, Nackaerts Kristiaan, Peled Nir, Prokop Mathias, Remy-Jardin Martine, von Stackelberg Oyunbileg, Sculier Jean-Paul Eur Respir J 2015; 46: 28-39
Combined endobronchial and oesophageal endosonography for the diagnosis and staging of lung cancer Vilmann Peter, Clementsen Paul Frost, Colella Sara, Siemsen Mette, De Leyn Paul, Dumonceau Jean-Marc, Herth Felix J., Larghi Alberto, Vazquez-Sequeiros Enrique, Hassan Cesare, Crombag Laurence, Korevaar Daniël A., Konge Lars, Annema Jouke T. Eur Respir J 2015; 46: 40-60
Statement on smoking cessation in COPD and other pulmonary diseases and in smokers with comorbidities who find it difficult to quit Jiménez-Ruiz Carlos A., Andreas Stefan, Lewis Keir E., Tonnesen Philip, van Schayck C.P., Hajek Peter, Tonstad Serena, Dautzenberg Bertrand, Fletcher Monica, Masefield Sarah, Powell Pippa, Hering Thomas, Nardini Stefano, Tonia Thomy, Gratziou Christina Eur Respir J 2015; 46: 61-79
Effects of quitting cannabis on respiratory symptoms Hancox Robert J., Shin Hayden H., Gray Andrew R., Poulton Richie, Sears Malcolm R. Eur Respir J 2015; 46: 80-87
Gait patterns in COPD: the Rotterdam Study Lahousse Lies, Verlinden Vincentius J.A., van der Geest Jos N., Joos Guy F., Hofman Albert, Stricker Bruno H.C., Brusselle Guy G., Ikram M. Arfan Eur Respir J 2015; 46: 88-95
The relationship between asthma and suicidal behaviours: a systematic literature review Barker Emma, Kõlves Kairi, De Leo Diego Eur Respir J 2015; 46: 96-106
Sleeping on animal fur is related to asthma outcomes in later childhood Tischer Christina, Standl Marie, Lehmann Irina, Schaaf Beate, von Berg Andrea, Heinrich Joachim Eur Respir J 2015; 46: 107-114
Coeliac disease and asthma association in children: the role of antibiotic consumption Canova Cristina, Pitter Gisella, Ludvigsson Jonas F., Romor Pierantonio, Zanier Loris, Zanotti Renzo, Simonato Lorenzo Eur Respir J 2015; 46: 115-122
Airflow limitation by the Global Lungs Initiative equations in a cohort of very old adults Turkeshi Eralda, Vaes Bert, Andreeva Elena, Matheï Catharina, Adriaensen Wim, Van Pottelbergh Gijs, Degryse Jean-Marie Eur Respir J 2015; 46: 123-132
Future trends in cystic fibrosis demography in 34 European countries Burgel Pierre-Régis, Bellis Gil, Olesen Hanne V., Viviani Laura, Zolin Anna, Blasi Francesco, Elborn J. Stuart Eur Respir J 2015; 46: 133-141
Obstructive sleep apnoea in the elderly: role of continuous positive airway pressure treatment Martínez-García Miguel Ángel, Chiner Eusebi, Hernández Luis, Cortes Jose Pascual, Catalán Pablo, Ponce Silvia, Diaz Jose Ramón, Pastor Ester, Vigil Laura, Carmona Carmen, Montserrat Josep Maria, Aizpuru Felipe, Lloberes Patricia, Mayos Mercedes, Selma Maria José, Cifuentes Jose Fernando, Muñoz Alvaro Eur Respir J 2015; 46: 142-151
Validation of two predictive models for survival in pulmonary arterial hypertension Sitbon Olivier, Benza Raymond L., Badesch David B., Barst Robyn J., Elliott C. Gregory, Gressin Virginie, Lemarié Jean-Christophe, Miller Dave P., Muros-Le Rouzic Erwan, Simonneau Gérald, Frost Adaani E., Farber Harrison W., Humbert Marc, McGoon Michael D. Eur Respir J 2015; 46: 152-164
Decreasing cost effectiveness of testing for latent TB in HIV in a low TB incidence area Capocci Santino, Smith Colette, Morris Stephen, Bhagani Sanjay, Cropley Ian, Abubakar Ibrahim, Johnson Margaret, Lipman Marc Eur Respir J 2015; 46: 165-174
Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis Vorselaars Adriane D.M., Crommelin Heleen A., Deneer Vera H.M., Meek Bob, Claessen Anke M.E., Keijsers Ruth G.M., van Moorsel Coline H.M., Grutters Jan C. Eur Respir J 2015; 46: 175-185
Management of patients with idiopathic pulmonary fibrosis in clinical practice: the INSIGHTS-IPF registry Behr Jürgen, Kreuter Michael, Hoeper Marius M., Wirtz Hubert, Klotsche Jens, Koschel Dirk, Andreas Stefan, Claussen Martin, Grohé Christian, Wilkens Henrike, Randerath Winfried, Skowasch Dirk, Meyer F. Joachim, Kirschner Joachim, Gläser Sven, Herth Felix J.F., Welte Tobias, Huber Rudolf Maria, Neurohr Claus, Schwaiblmair Martin, Kohlhäufl Martin, Höffken Gert, Held Matthias, Koch Andrea, Bahmer Thomas, Pittrow David Eur Respir J 2015; 46: 186-196
Genotype alone does not predict the clinical course of SFTPC deficiency in paediatric patients Kröner Carolin, Reu Simone, Teusch Veronika, Schams Andrea, Grimmelt Ann-Christin, Barker Michael, Brand Joerg, Gappa Monika, Kitz Richard, Kramer Boris W., Lange Lars, Lau Susanne, Pfannenstiel Claus, Proesmans Marijke, Seidenberg Jürgen, Sismanlar Tugba, Aslan Ayse Tana, Werner Claudius, Zielen Stefan, Zarbock Ralf, Brasch Frank, Lohse Peter, Griese Matthias Eur Respir J 2015; 46: 197-206
French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas Lantuejoul Sylvie, Rouquette Isabelle, Blons Hélène, Le Stang Nolwenn, Ilie Marius, Begueret Hugues, Grégoire Valerie, Hofman Paul, Gros Audrey, Garcia Stephane, Monhoven Nathalie, Devouassoux-Shisheboran Mojgan, Mansuet-Lupo Audrey, Thivolet Françoise, Antoine Martine, Vignaud Jean-Michel, Penault-Llorca Frederique, Galateau-Sallé Françoise, McLeer-Florin Anne Eur Respir J 2015; 46: 207-218
Erlotinib and bevacizumab versus cisplatin, gemcitabine and bevacizumab in unselected nonsquamous nonsmall cell lung cancer Thomas Michael, Fischer Jürgen, Andreas Stefan, Kortsik Cornelius, Grah Christian, Serke Monika, von Eiff Michael, Witt Christian, Kollmeier Jens, Müller Ernst, Schenk Michael, Schröder Michael, Villalobos Matthias, Reinmuth Niels, Penzel Roland, Schnabel Philipp, Acker Thomas, Reuss Alexander, Wolf Martin Eur Respir J 2015; 46: 219-229
Therapeutic management of ALK+ nonsmall cell lung cancer patients Duchemann Boris, Friboulet Luc, Besse Benjamin Eur Respir J 2015; 46: 230-242
A new era in idiopathic pulmonary fibrosis: considerations for future clinical trials Collard Harold R., Bradford Williamson Z., Cottin Vincent, Flaherty Kevin R., King Talmadge E., Koch Gary G., Kolb Martin, Martinez Fernando J., Montgomery Bruce, Raghu Ganesh, Richeldi Luca, Rose Dan, Wells Athol U., Brown Kevin K. Eur Respir J 2015; 46: 243-249
Clinical and prognostic heterogeneity of C and D GOLD groups Agustí Alvar, Rennard Stephen, Edwards Lisa D., MacNee William, Wouters Emiel, Miller Bruce, Tal-Singer Ruth, Mullerova Hana, Celli Bartolomé Eur Respir J 2015; 46: 250-254
Efficacy of an inhaled corticosteroid/long-acting ?2-agonist combination in symptomatic COPD patients in GOLD groups B and D Anzueto Antonio, Jenkins Christine R., Make Barry J., Lindberg Magnus, Calverley Peter M., Fagerås Malin, Postma Dirkje S., Rennard Stephen I., Tashkin Donald P. Eur Respir J 2015; 46: 255-258
Occupational exposures and fluorescent oxidation products in 723 adults of the EGEA study Dumas Orianne, Matran Régis, Zerimech Farid, Decoster Brigitte, Huyvaert Helene, Ahmed Ismail, Le Moual Nicole, Nadif Rachel Eur Respir J 2015; 46: 258-261
Global Lung Function Initiative equations improve interpretation of FEV1 decline among patients with cystic fibrosis Stanojevic Sanja, Bilton Diana, McDonald Alexandra, Stocks Janet, Aurora Paul, Prasad Ammani, Cole Tim J., Davies Gwyneth Eur Respir J 2015; 46: 262-264
Public awareness on cystic fibrosis: results from a national pragmatic survey Braido Fulvio, Baiardini Ilaria, Sumberesi Massimo, Canonica Giorgio Walter, Blasi Francesco, Castellani Carlo Eur Respir J 2015; 46: 264-267
An interlaboratory quality control programme for the measurement of tuberculosis drugs Aarnoutse Rob E., Sturkenboom Marieke G.G., Robijns Karen, Harteveld Anneke R., Greijdanus Ben, Uges Donald R.A., Touw Daniel J., Alffenaar Jan-Willem Eur Respir J 2015; 46: 268-271
Linezolid for multidrug-resistant tuberculosis in HIV-infected and -uninfected patients Hughes Jennifer, Isaakidis Petros, Andries Aristomo, Mansoor Homa, Cox Vivian, Meintjes Graeme, Cox Helen Eur Respir J 2015; 46: 271-274
Is Europe ready to reach tuberculosis elimination? An outbreak report from Southern Italy Gillini Laura, Centis Rosella, D'Ambrosio Lia, Fedele Alberto, Aprile Valerio, Pasanisi Giancarlo, Donateo Leonardo, Costa Danila, Migliori Giovanni Battista, Tundo Paolo Eur Respir J 2015; 46: 274-277
Discrepant elevation of sIL-2R levels in sarcoidosis patients with renal insufficiency Verwoerd Anouk, Vorselaars Adriane D.M., van Moorsel Coline H.M., Bos Willem Jan W., van Velzen-Blad Heleen, Grutters Jan C. Eur Respir J 2015; 46: 277-280
10-year long-term survival of a metastatic EGFR-mutated nonsmall cell lung cancer patient Kempf Emmanuelle, Planchard David, Le Chevalier Thierry, Soria Jean-Charles Eur Respir J 2015; 46: 280-282
Oral vasopressin receptor antagonist tolvaptan in right heart failure due to pulmonary hypertension Tamura Yuichi, Kimura Mai, Takei Makoto, Ono Tomohiko, Kuwana Masataka, Satoh Toru, Fukuda Keiichi, Humbert Marc Eur Respir J 2015; 46: 283-286
Airway diseases and inflammatory bowel diseases: is it something in the air (pollution)? Hirota Jeremy A., Carlsten Chris, Sadatsafavi Mohsen, Kaplan Gilaad, Hirota Simon A. Eur Respir J 2015; 46: 287-288
Bedaquiline: finding the pores on the pot Mohapatra Prasanta Raghab Eur Respir J 2015; 46: 288-289
Bedaquiline: finding the pores on the pot Salfinger Max, Migliori Giovanni Battista Eur Respir J 2015; 46: 289-291